Business ❯ Pharmaceuticals

Market Trends

Revenue Growth Weight Loss Drugs Drug Development US Market Pricing Strategies Domestic Market Company Acquisitions Vertical Integration Drug Patents China Competitor Analysis Product Launches Reshoring Acquisitions Dietary Supplements Patent Expirations Biologics Prescription Drugs Sales Growth Growth Cycles M&A Activity Biomanufacturing Competition Consumer Demand Vaccine Sales Generic Drugs Drug Supply Shortages Stock Listings Retail Pharmacy Investment Strategies Drug Pricing Sales Forecasts Patent Expiration Drug Pipeline Growth Strategies Acquisition Strategies Weight Loss Medications Chronic Therapy Stock Performance Cost of Treatments Consumer Health Products

CVS Caremark Reverses Exclusion and Adds Lilly’s Foundayo and Zepbound to Its Formulary

Formulary parity across the three largest U.S. PBMs will expand insured access to Lilly’s obesity drugs.

AbbVie Tops Q1 and Raises 2026 Outlook as Skyrizi and Rinvoq Offset Humira Decline

West Pharmaceutical Raises 2026 Guidance After Double-Digit Q1 Growth

Novartis to Acquire Excellergy in Up to $2 Billion Deal for Next-Gen Anti-IgE

Telix Confirms Webcast Investor Sessions at Oppenheimer and TD Cowen Conferences

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

Novartis Posts Q3 Sales Rise but Misses Views, Reaffirms 2025 Outlook

Pfizer Strikes U.S. Drug-Pricing Pact, Wins Exemption From 100% Import Tariff